DEXAMETHASONE 5 MG/ML SOLUTION

Land: Canada

Taal: Engels

Bron: Health Canada

Werkstoffen:

DEXAMETHASONE SODIUM PHOSPHATE

Beschikbaar vanaf:

ALBERTA VETERINARY LABORATORIES LTD

Dosering:

5MG

farmaceutische vorm:

SOLUTION

Samenstelling:

DEXAMETHASONE SODIUM PHOSPHATE 5MG

Toedieningsweg:

INTRAMUSCULAR

Eenheden in pakket:

100ML

Prescription-type:

OTC

Therapeutische categorie:

CATTLE; CATTLE; CATTLE; HORSES; CATS; DOGS

Product samenvatting:

Active ingredient group (AIG) number: 0131220002

Autorisatie-status:

APPROVED

Autorisatie datum:

2018-05-16

Bijsluiter

160 mm
65 mm
Dexamethasone 5 mg/mL 100mL Bottle Label Mock-Up
Label Size:
160mm x 65mm Rectangle
Colours:
Black and white only, no graphics
Font Style:
Arial; Arial Narrow
Font Sizes:
Product name - 11
Proper name - 6
DIN & Sterile - 7
Warning and Manufacturer Address - 6
Volume - 10
Expiry - 8
English and French Panel Text - 4.5
Date of Preparation
April 24 2018
DEXAMETHASONE 5 MG/ML
Dexamethasone Injection, USP 5 mg/mL
Injection de dexaméthasone, USP 5 mg/mL.
STERILE/ STÉRILE | DIN XXXXXXXX
Veterinary Use Only/ Usage Vétérinaire Seulement
WARNINGS: KEEP OUT OF REACH OF CHILDREN. THIS
DRUG IS NOT TO BE ADMINISTERED TO HORSES THAT
ARE TO BE SLAUGHTERED FOR USE IN FOOD. NO
WITHDRAWAL PERIOD FOR MEAT AND WITHHOLDING
TIME FOR MILK ARE REQUIRED WHEN USED ACCORDING
TO THE LABEL.
MISES EN GARDE : GARDER HORS DE PORTÉE DES
ENFANTS. CE MÉDICAMENT NE DOIT PAS ÊTRE
ADMINISTRÉ AUX CHEVAUX DEVANT ÊTRE ABATTUS À
DES FINS ALIMENTAIRES. UN DÉLAI D’ATTENTE N’EST
PAS REQUIS POUR VIANDE ET UNE PÉRIODE DE RETRAIT
POUR LE LAIT QUAND LES DIRECTIVES DE L’ÉTIQUETTE
SONT SUIVIES.
ALBERTA VETERINARY LABORATORIES LTD.
411 – 19th Street SE, Calgary, AB T2E 6J7
100 ML
Lot: XXXXXXXX
EXP: MMYY
ACTIVE INGREDIENTS : Each mL contains: Dexamethasone sodium phosphate
5 mg
Preservatives (per mL): Methylparaben 1mg Propylparaben 0.1 mg
INDICATIONS: Dexamethasone 5 mg/mL is indicated as an aid in the
treatment of bovine
ketosis and as an anti-inflammatory agent in dogs, cats, cattle and
horses. Small animal
indications include inflammatory conditions involving the joints
(where structural changes such
as ankylosing joints, ruptured ligaments, sheaths, etc. do not exist)
and nonspecific dermatitis.
Equine indications include bursitis, carpitis, osselets, tendinitis,
myositis, sprains and as
supportive therapy in fatigue, heat exhaustion and acute infectious
diseases. If bony changes
exist in any of these conditions, a response to Dexamethasone 5 mg/mL
cannot be expected.
DOSAGE AND ADMINISTRATION: Therapy with Dexamethasone 5 mg/m